The Institute's recent open day featured hands-on displays and demonstrations, including 3-D printing of tissue-scaffolds for ear and nose replacement. Visitors chatted eagerly with scientists about their research, and heard presentations about ground-breaking work to develop new treatments for diseases including type-1 diabetes, cancer, scleroderma and hepatitis as well as HIV vaccines and artificial tissues and organs for transplantation.
Professor Hans Stauss, Co-Director of UCL’s Division of Infection and Immunity, and Professor Michael Arthur, UCL President and Provost, visited the UAE to raise the profile of the Institute of Immunity and Transplantation and of UCL’s research on new treatments for diabetes, cancer, haemophilia and other diseases affecting the region. The academics met alumni and donors during their April 2014 trip, with the support of UCL’s Development and Alumni Relations team. More...
The Institute is being planned in two phases, to kick-start expansion of research activity while working towards the vision of a truly world-class centre.
- UCL and the Royal Free London NHS Foundation Trust fully financed the £6 million Phase I development of the Institute, completed in May 2013.
- We have now launched a £47 million fundraising campaign for Phase II.
Page last modified on 06 dec 13 15:13